LIN7C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.760800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.894000E-01
Normal-vs-Stage2
4.974200E-01
Normal-vs-Stage3
5.562800E-01
Normal-vs-Stage4
2.300000E-01
Stage1-vs-Stage2
9.815600E-01
Stage1-vs-Stage3
1.377610E-01
Stage1-vs-Stage4
3.414600E-01
Stage2-vs-Stage3
1.565010E-01
Stage2-vs-Stage4
2.755400E-01
Stage3-vs-Stage4
1.253150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.899400E-01
Normal-vs-AfricanAmerican
2.569400E-01
Normal-vs-Asian
6.279600E-01
Caucasian-vs-AfricanAmerican
5.991000E-01
Caucasian-vs-Asian
8.560800E-01
AfricanAmerican-vs-Asian
6.154400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.437400E-01
Normal-vs-Female
5.041200E-01
Male-vs-Female
9.433400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.485000E-01
Normal-vs-Age(41-60Yrs)
2.379600E-01
Normal-vs-Age(61-80Yrs)
5.891600E-01
Normal-vs-Age(81-100Yrs)
7.944400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.887400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.671000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.937000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.027800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.936200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.724400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.872000E-01
Normal-vs-Daily Drinker
6.029200E-01
Normal-vs-Weekly Drinker
8.975400E-01
Normal-vs-Occasional Drinker
1.739990E-01
Normal-vs-Social Drinker
5.139000E-01
Non Drinker-vs-Daily Drinker
9.642000E-01
Non Drinker-vs-Weekly Drinker
2.183000E-01
Non Drinker-vs-Occasional Drinker
1.910360E-02
Non Drinker-vs-Social Drinker
5.507000E-01
Daily Drinker-vs-Weekly Drinker
2.517600E-01
Daily Drinker-vs-Occasional Drinker
2.844200E-02
Daily Drinker-vs-Social Drinker
5.567400E-01
Weekly Drinker-vs-Occasional Drinker
6.900800E-03
Weekly Drinker-vs-Social Drinker
1.666580E-01
Occasional Drinker-vs-Social Drinker
1.982810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.400300E-02
Normal-vs-Grade 2
7.063500E-03
Normal-vs-Grade 3
4.238000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.687200E-01
Grade 1-vs-Grade 3
5.957600E-01
Grade 1-vs-Grade 4
4.400300E-02
Grade 2-vs-Grade 3
8.472000E-01
Grade 2-vs-Grade 4
7.063500E-03
Grade 3-vs-Grade 4
4.238000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.181800E-01
Normal-vs-NonDiabetic
4.570600E-01
Diabetic-vs-NonDiabetic
1.834030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.933800E-01
Normal-vs-NoPancreatitis
4.981600E-01
Pancreatitis-vs-NoPancreatitis
1.768370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.140600E-01
Normal-vs-N1
5.010000E-01
N0-vs-N1
7.156000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.978000E-03
Normal-vs-TP53-NonMutant
6.534400E-02
TP53-Mutant-vs-TP53-NonMutant
7.708300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
